Skip to Main Content
Diseases of the Digestive System - Small Intestines, Large Intestines & Rectum, Phase III

A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease

What is the purpose of this trial?

Brief Summary:

This is a Phase 3, randomized, double-blind, placebo-controlled study to demonstrate the effect of oral ozanimod as maintenance therapy in subjects with moderately to severely active Crohn's Disease.

  • Trial with
    Celgene Corporation
  • Ages
    18 years - 75 years
  • Gender
    Both

Contact Information

For more information about this study, including how to volunteer, contact Elizabeth Ruggiero

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

  • Last Updated
    07/23/2024
  • Study HIC
    #2000024497